1. Home
  2. LODE vs PLX Comparison

LODE vs PLX Comparison

Compare LODE & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

BUY

Current Price

$1.78

Market Cap

161.9M

Sector

Industrials

ML Signal

BUY

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.55

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LODE
PLX
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
207.1M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
LODE
PLX
Price
$1.78
$2.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.5M
840.6K
Earning Date
11-02-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.55
N/A
EPS
N/A
★ 0.27
Revenue
$1,553,796.00
★ $52,744,000.00
Revenue This Year
$303.79
$55.77
Revenue Next Year
$410.04
N/A
P/E Ratio
★ N/A
$9.57
Revenue Growth
N/A
★ N/A
52 Week Low
$1.70
$1.65
52 Week High
$4.98
$3.19

Technical Indicators

Market Signals
Indicator
LODE
PLX
Relative Strength Index (RSI) 23.75 42.21
Support Level N/A $2.21
Resistance Level $3.32 $2.75
Average True Range (ATR) 0.11 0.10
MACD -0.01 -0.03
Stochastic Oscillator 11.29 7.41

Price Performance

Historical Comparison
LODE
PLX

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: